Investor List:

Top Drug Delivery Pre-Seed Investors in Boston / New England (7)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Drug Delivery investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Milad Alucozai, Investor at BoxOne Ventures
Milad Alucozai
BoxOne Ventures·Investor
Sweet spot: $300K
Range: $100K - $1M
Investors in Boston (MA), Investors in Chicago (IL), Investors in Montreal, Investors in Toronto (Ontario), Investors in San Francisco (CA)
Investors in Drug Delivery (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in BioTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Hardware (Pre-seed), Investors in Digital Health (Pre-seed), Investors in AI (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in AI (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Hardware (Pre-seed), Investors in Analytics (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Analytics (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Pre-seed), Investors in Hardware (Pre-seed), Investors in AI (Pre-seed), Investors in Health IT (Pre-seed), Investors in Analytics (Pre-seed), Investors in SaaS (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Digital Health (Pre-seed), Investors in SaaS (Pre-seed), Investors in BioTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health IT (Pre-seed), Investors in Hardware (Pre-seed), Investors in SaaS (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Analytics (Pre-seed), Investors in Health IT (Pre-seed), Investors in AI (Pre-seed), Investors in Hardware (Pre-seed), Investors in Digital Health (Pre-seed), Investors in AI (Pre-seed), Investors in Analytics (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Pre-seed), Investors in SaaS (Pre-seed), Investors in SaaS (Pre-seed), Investors in Drug Delivery (Seed), Investors in Pharmaceuticals (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Hardware (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in AI (Seed), Investors in Drug Delivery (Seed), Investors in Analytics (Seed), Investors in Pharmaceuticals (Seed), Investors in Health IT (Seed), Investors in Digital Health (Seed), Investors in AI (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Analytics (Seed), Investors in Hardware (Seed), Investors in Health & Hospital Services (Seed), Investors in AI (Seed), Investors in Hardware (Seed), Investors in SaaS (Seed), Investors in Health IT (Seed), Investors in Analytics (Seed), Investors in Digital Health (Seed), Investors in SaaS (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Hardware (Seed), Investors in BioTech (Seed), Investors in SaaS (Seed), Investors in Digital Health (Seed), Investors in Analytics (Seed), Investors in Hardware (Seed), Investors in AI (Seed), Investors in Health & Hospital Services (Seed), Investors in AI (Seed), Investors in Health IT (Seed), Investors in Digital Health (Seed), Investors in Analytics (Seed), Investors in SaaS (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in SaaS (Seed), Investors in British Columbia (Other Lists), Investors in Midwest (Other Lists), Investors in Diverse Investors (Other Lists), Investors in Boston / New England (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Jorge Cortell, General Partner at Unveil Pharma
Jorge Cortell
Unveil Pharma·General Partner
Sweet spot: $1.5M
Range: $500K - $20.0M
Investors in Cambridge (MA), Investors in Boston (MA), Investors in Singapore
Investors in Drug Delivery (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health IT (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health IT (Pre-seed), Investors in Diagnostics (Seed), Investors in Therapeutics (Seed), Investors in Drug Delivery (Seed), Investors in Medical Devices (Seed), Investors in Therapeutics (Seed), Investors in Drug Delivery (Seed), Investors in Pharmaceuticals (Seed), Investors in Diagnostics (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Diagnostics (Series A), Investors in Therapeutics (Series A), Investors in Medical Devices (Series A), Investors in Drug Delivery (Series A), Investors in Therapeutics (Series A), Investors in Diagnostics (Series A), Investors in Pharmaceuticals (Series A), Investors in Drug Delivery (Series A), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Boston / New England (Other Lists), Investors in Diverse Investors (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists)
Photo of Eyal S Ron, Managing Partner at SenseAI Ventures
Eyal S Ron
SenseAI Ventures·Managing Partner
Sweet spot: $15K
Range: $10K - $250K
Investors in Boston (MA)
Photo of Chris Leiter, Atria Ventures
Chris Leiter
Sweet spot: $800K
Range: $250K - $2.0M
Investors in Basel, Investors in Zurich, Investors in Berlin (Germany), Investors in London, Investors in Chicago (IL), Investors in San Diego (CA), Investors in Boston (MA), Investors in New York (NY), Investors in San Francisco (CA)
Investors in Drug Delivery (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Digital Health (Pre-seed), Investors in DeepTech (Pre-seed), Investors in DeepTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Health IT (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in DeepTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health IT (Pre-seed), Investors in Health IT (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Health IT (Pre-seed), Investors in BioTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in Digital Health (Pre-seed), Investors in SaaS (Pre-seed), Investors in DeepTech (Pre-seed), Investors in SaaS (Pre-seed), Investors in Digital Health (Pre-seed), Investors in SaaS (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in SaaS (Pre-seed), Investors in Health IT (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health IT (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in SaaS (Pre-seed), Investors in DeepTech (Pre-seed), Investors in SaaS (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health IT (Pre-seed), Investors in SaaS (Pre-seed), Investors in Midwest (Other Lists), Investors in Los Angeles / Southern California (Other Lists), Investors in Diverse Investors (Other Lists), Investors in Boston / New England (Other Lists), Investors in London (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in New York City (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Amad Elia, Venture Partner at Ganas Ventures
Amad Elia
Ganas Ventures·Venture Partner
Sweet spot: $50K
Range: $50K - $100K
Investors in Chicago (IL), Investors in Ann Arbor (MI), Investors in San Francisco (CA), Investors in Boston (MA)
Investors in Direct-to-Consumer (DTC) (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Direct-to-Consumer (DTC) (Pre-seed), Investors in Gaming/eSports (Pre-seed), Investors in AR/VR (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Gaming/eSports (Pre-seed), Investors in AR/VR (Pre-seed), Investors in Direct-to-Consumer (DTC) (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in E-commerce (Pre-seed), Investors in E-commerce (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in AI (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Gaming/eSports (Pre-seed), Investors in BioTech (Pre-seed), Investors in AR/VR (Pre-seed), Investors in Digital Health (Pre-seed), Investors in AI (Pre-seed), Investors in Direct-to-Consumer (DTC) (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in BioTech (Pre-seed), Investors in E-commerce (Pre-seed), Investors in AR/VR (Pre-seed), Investors in Gaming/eSports (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in AI (Pre-seed), Investors in E-commerce (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in AI (Pre-seed), Investors in Drug Delivery (Seed), Investors in Direct-to-Consumer (DTC) (Seed), Investors in Direct-to-Consumer (DTC) (Seed), Investors in Generative Tech/AI (Seed), Investors in Generative Tech/AI (Seed), Investors in Drug Delivery (Seed), Investors in AR/VR (Seed), Investors in AR/VR (Seed), Investors in Drug Delivery (Seed), Investors in Gaming/eSports (Seed), Investors in Direct-to-Consumer (DTC) (Seed), Investors in Gaming/eSports (Seed), Investors in Drug Delivery (Seed), Investors in E-commerce (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in E-commerce (Seed), Investors in Generative Tech/AI (Seed), Investors in AI (Seed), Investors in Gaming/eSports (Seed), Investors in AR/VR (Seed), Investors in Direct-to-Consumer (DTC) (Seed), Investors in AI (Seed), Investors in Generative Tech/AI (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in AR/VR (Seed), Investors in E-commerce (Seed), Investors in Digital Health (Seed), Investors in Gaming/eSports (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in AI (Seed), Investors in Digital Health (Seed), Investors in E-commerce (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in AI (Seed), Investors in Direct-to-Consumer (DTC) (Series A), Investors in Drug Delivery (Series A), Investors in Direct-to-Consumer (DTC) (Series A), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Series A), Investors in AR/VR (Series A), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series A), Investors in AR/VR (Series A), Investors in Gaming/eSports (Series A), Investors in Direct-to-Consumer (DTC) (Series A), Investors in Gaming/eSports (Series A), Investors in E-commerce (Series A), Investors in Drug Delivery (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in AI (Series A), Investors in E-commerce (Series A), Investors in Generative Tech/AI (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series A), Investors in AR/VR (Series A), Investors in Direct-to-Consumer (DTC) (Series A), Investors in AI (Series A), Investors in Gaming/eSports (Series A), Investors in Generative Tech/AI (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series A), Investors in AR/VR (Series A), Investors in E-commerce (Series A), Investors in Digital Health (Series A), Investors in Gaming/eSports (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series A), Investors in AI (Series A), Investors in E-commerce (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series A), Investors in AI (Series A), Investors in Digital Health (Series A), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series B), Investors in Direct-to-Consumer (DTC) (Series B), Investors in Direct-to-Consumer (DTC) (Series B), Investors in Drug Delivery (Series B), Investors in Generative Tech/AI (Series B), Investors in Gaming/eSports (Series B), Investors in Generative Tech/AI (Series B), Investors in AR/VR (Series B), Investors in AR/VR (Series B), Investors in Gaming/eSports (Series B), Investors in Direct-to-Consumer (DTC) (Series B), Investors in E-commerce (Series B), Investors in Drug Delivery (Series B), Investors in E-commerce (Series B), Investors in Generative Tech/AI (Series B), Investors in Digital Health (Series B), Investors in AI (Series B), Investors in AR/VR (Series B), Investors in Health & Hospital Services (Series B), Investors in Direct-to-Consumer (DTC) (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Gaming/eSports (Series B), Investors in Digital Health (Series B), Investors in Generative Tech/AI (Series B), Investors in Health & Hospital Services (Series B), Investors in AR/VR (Series B), Investors in BioTech (Series B), Investors in E-commerce (Series B), Investors in Digital Health (Series B), Investors in Gaming/eSports (Series B), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in E-commerce (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Midwest (Other Lists), Investors in Boston / New England (Other Lists), Investors in Diverse Investors (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in San Francisco Bay Area (Other Lists), Investors in Investors who invested in female founders (Other Lists)
Photo of Eric Anschutz
Eric Anschutz
Sweet spot: $25K
Range: $10K - $250K
Investors in Boston (MA), Investors in San Francisco (CA), Investors in Shanghai, Investors in Los Angeles (CA), Investors in San Diego (CA), Investors in San Jose (CA), Investors in Oakland (CA), Investors in Emeryville (CA), Investors in Seattle (WA), Investors in British Columbia
Investors in Material Science (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Space (Pre-seed), Investors in Material Science (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Space (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Material Science (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in BioTech (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Material Science (Pre-seed), Investors in Space (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in BioTech (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Space (Pre-seed), Investors in Material Science (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in AI (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in BioTech (Pre-seed), Investors in AI (Pre-seed), Investors in Space (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in BioTech (Pre-seed), Investors in DeepTech (Pre-seed), Investors in AI (Pre-seed), Investors in AI (Pre-seed), Investors in Material Science (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in BioTech (Pre-seed), Investors in Space (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in DeepTech (Pre-seed), Investors in AI (Pre-seed), Investors in BioTech (Pre-seed), Investors in AI (Pre-seed), Investors in Drug Delivery (Seed), Investors in Material Science (Seed), Investors in Drug Delivery (Seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Seed), Investors in Drug Delivery (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Material Science (Seed), Investors in Generative Tech/AI (Seed), Investors in Space (Seed), Investors in DeepTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Space (Seed), Investors in Drug Delivery (Seed), Investors in Generative Tech/AI (Seed), Investors in Generative Tech/AI (Seed), Investors in Drug Delivery (Seed), Investors in DeepTech (Seed), Investors in Material Science (Seed), Investors in Generative Tech/AI (Seed), Investors in Diagnostics (Seed), Investors in Pharmaceuticals (Seed), Investors in Material Science (Seed), Investors in Therapeutics (Seed), Investors in Space (Seed), Investors in BioTech (Seed), Investors in Therapeutics (Seed), Investors in DeepTech (Seed), Investors in Space (Seed), Investors in Diagnostics (Seed), Investors in DeepTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Drug Delivery (Seed), Investors in Material Science (Seed), Investors in AI (Seed), Investors in Therapeutics (Seed), Investors in BioTech (Seed), Investors in Diagnostics (Seed), Investors in Generative Tech/AI (Seed), Investors in AI (Seed), Investors in Space (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in AI (Seed), Investors in Generative Tech/AI (Seed), Investors in DeepTech (Seed), Investors in AI (Seed), Investors in Pharmaceuticals (Seed), Investors in Material Science (Seed), Investors in Therapeutics (Seed), Investors in Diagnostics (Seed), Investors in BioTech (Seed), Investors in Space (Seed), Investors in BioTech (Seed), Investors in DeepTech (Seed), Investors in Pharmaceuticals (Seed), Investors in AI (Seed), Investors in BioTech (Seed), Investors in AI (Seed), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series A), Investors in Material Science (Series A), Investors in Material Science (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Drug Delivery (Series A), Investors in Space (Series A), Investors in Generative Tech/AI (Series A), Investors in DeepTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Space (Series A), Investors in Generative Tech/AI (Series A), Investors in Drug Delivery (Series A), Investors in Diagnostics (Series A), Investors in Generative Tech/AI (Series A), Investors in Drug Delivery (Series A), Investors in Material Science (Series A), Investors in DeepTech (Series A), Investors in Generative Tech/AI (Series A), Investors in Material Science (Series A), Investors in Space (Series A), Investors in Therapeutics (Series A), Investors in BioTech (Series A), Investors in Therapeutics (Series A), Investors in Pharmaceuticals (Series A), Investors in Therapeutics (Series A), Investors in DeepTech (Series A), Investors in AI (Series A), Investors in Space (Series A), Investors in DeepTech (Series A), Investors in Diagnostics (Series A), Investors in Drug Delivery (Series A), Investors in Pharmaceuticals (Series A), Investors in Material Science (Series A), Investors in BioTech (Series A), Investors in Diagnostics (Series A), Investors in Generative Tech/AI (Series A), Investors in AI (Series A), Investors in Space (Series A), Investors in Generative Tech/AI (Series A), Investors in AI (Series A), Investors in BioTech (Series A), Investors in AI (Series A), Investors in Pharmaceuticals (Series A), Investors in Therapeutics (Series A), Investors in Material Science (Series A), Investors in DeepTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Diagnostics (Series A), Investors in BioTech (Series A), Investors in Space (Series A), Investors in BioTech (Series A), Investors in DeepTech (Series A), Investors in AI (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in AI (Series A), Investors in Therapeutics (Series B), Investors in Material Science (Series B), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series B), Investors in Diagnostics (Series B), Investors in Material Science (Series B), Investors in Generative Tech/AI (Series B), Investors in DeepTech (Series B), Investors in Therapeutics (Series B), Investors in Space (Series B), Investors in Diagnostics (Series B), Investors in Space (Series B), Investors in Diagnostics (Series B), Investors in Drug Delivery (Series B), Investors in Material Science (Series B), Investors in Generative Tech/AI (Series B), Investors in DeepTech (Series B), Investors in Pharmaceuticals (Series B), Investors in Generative Tech/AI (Series B), Investors in Material Science (Series B), Investors in Generative Tech/AI (Series B), Investors in Space (Series B), Investors in Therapeutics (Series B), Investors in Therapeutics (Series B), Investors in Pharmaceuticals (Series B), Investors in DeepTech (Series B), Investors in Space (Series B), Investors in Therapeutics (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Material Science (Series B), Investors in Drug Delivery (Series B), Investors in Pharmaceuticals (Series B), Investors in DeepTech (Series B), Investors in AI (Series B), Investors in Diagnostics (Series B), Investors in Space (Series B), Investors in Generative Tech/AI (Series B), Investors in Diagnostics (Series B), Investors in AI (Series B), Investors in Generative Tech/AI (Series B), Investors in Therapeutics (Series B), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Material Science (Series B), Investors in Pharmaceuticals (Series B), Investors in DeepTech (Series B), Investors in Diagnostics (Series B), Investors in BioTech (Series B), Investors in Space (Series B), Investors in BioTech (Series B), Investors in DeepTech (Series B), Investors in AI (Series B), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in British Columbia (Other Lists), Investors in Seattle / Portland (Other Lists), Investors in Los Angeles / Southern California (Other Lists), Investors in Boston / New England (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in San Francisco Bay Area (Other Lists)
NS
Noam Sahbti
Partner
Sweet spot: $300K
Range: $100K - $500K
Investors in United States, Investors in Israel, Investors in Boston / New England
Investors in Therapeutics (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Insurance (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Real Estate/PropTech (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Real Estate/PropTech (Pre-seed), Investors in Insurance (Pre-seed), Investors in BioTech (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in BioTech (Pre-seed), Investors in AI (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in AI (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Insurance (Pre-seed), Investors in Real Estate/PropTech (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in AI (Pre-seed), Investors in Therapeutics (Seed), Investors in Drug Delivery (Seed), Investors in Diagnostics (Seed), Investors in Drug Delivery (Seed), Investors in Pharmaceuticals (Seed), Investors in Therapeutics (Seed), Investors in Insurance (Seed), Investors in Real Estate/PropTech (Seed), Investors in Medical Devices (Seed), Investors in Diagnostics (Seed), Investors in BioTech (Seed), Investors in Drug Delivery (Seed), Investors in Digital Health (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in AI (Seed), Investors in Insurance (Seed), Investors in Real Estate/PropTech (Seed), Investors in AI (Seed), Investors in Digital Health (Seed), Investors in Therapeutics (Seed), Investors in Diagnostics (Seed), Investors in BioTech (Seed), Investors in Insurance (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Real Estate/PropTech (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in AI (Seed), Investors in Israel (Other Lists), Investors in Female Investors (Other Lists), Investors in Boston / New England (Other Lists), Investors in Angel, Scout, and Solo-Capitalists (Other Lists)
Get new data & insights delivered to your inbox